A 62-year-old woman with a new diagnosis of breast cancer

JAMA. 2006 Mar 22;295(12):1434-42. doi: 10.1001/jama.295.12.1434.
No abstract available

Publication types

  • Case Reports
  • Clinical Conference

MeSH terms

  • Androstadienes / adverse effects
  • Androstadienes / economics
  • Androstadienes / therapeutic use
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / economics
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / adverse effects
  • Aromatase Inhibitors / economics
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / therapy*
  • Carcinoma, Lobular / diagnosis
  • Carcinoma, Lobular / therapy*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Decision Making
  • Female
  • Humans
  • Mastectomy, Segmental
  • Middle Aged
  • Prognosis
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / economics
  • Selective Estrogen Receptor Modulators / therapeutic use*
  • Tamoxifen / adverse effects
  • Tamoxifen / economics
  • Tamoxifen / therapeutic use*

Substances

  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • exemestane